J&J eyes one billion doses of potential COVID-19 shot in 2021, weighs challenge trials
Johnson & Johnson (J&J) could produce 1 billion doses of its potential COVID-19 vaccine next year ...
Johnson & Johnson (J&J) could produce 1 billion doses of its potential COVID-19 vaccine next year ...
Johnson and Johnson’s SPRAVATO® is the first and only approved medicine that has been shown to ...
A Johnson & Johnson executive said Sunday that the company’s goal is to deliver 1 ...